Stuart A Kingsley bought INDV once, on Mar 6, 2026
Director at Indivior Pharmaceuticals, Inc.
SEC CIK 0001369067 · Filings on SEC.gov ↗
Stuart A Kingsley's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Every filing
1 filing since Mar 2026, newest first
About Stuart A Kingsley
Stuart A. (Tony) Kingsley is a corporate insider and independent non‑executive director of Indivior Pharmaceuticals, Inc. (NASDAQ: INDV), where he serves on the board and participates in the company’s governance and strategic oversight.( SEC filings list him as "Kingsley Stuart A" in his capacity as a Director of Indivior, and insider trading reports show that he directly owns several thousand shares in the company following recent open‑market purchases.( In March 2026, he acquired 940 shares of Indivior common stock at approximately $31.87 per share, increasing his direct beneficial ownership to 5,582 shares.(
In addition to his Indivior role, Mr. Kingsley is identified in company documents as Stuart A. (Tony) Kingsley, and external corporate records list him as Stuart Anthony Kingsley, an American national with board appointments at Indivior‑related entities in the United Kingdom.( Management data for Indivior describe him as an Independent Non‑Executive Director with compensation aligned to board service rather than operational management.( Publicly available filings and summaries emphasize his responsibilities as a director and insider but do not provide detailed information on his prior career history or formal education; these aspects remain undisclosed in the accessible sources.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.